Chimin(603222)

Search documents
济民健康录得9天5板
Zheng Quan Shi Bao Wang· 2025-09-08 02:05
Summary of Key Points Core Viewpoint - Jimin Health has experienced significant stock price fluctuations, achieving five trading halts within nine trading days, resulting in a cumulative increase of 26.62% and a turnover rate of 156.83% [2]. Trading Performance - As of 9:38 AM, the stock recorded a trading volume of 25.996 million shares and a transaction amount of 291 million yuan, with a turnover rate of 4.95% [2]. - The total market capitalization of Jimin Health reached 6.07 billion yuan [2]. Margin Trading Data - The latest margin trading balance as of September 5 is 199 million yuan, with a financing balance of 198 million yuan, reflecting an increase of 29.105 million yuan or 17.19% compared to the previous trading day. However, over the past nine days, the cumulative decrease is 76.109 million yuan, representing a decline of 27.72% [2]. Stock Performance Metrics - The stock has been listed on the Dragon and Tiger list three times due to significant price deviations, with a cumulative deviation of 20% over three trading days, a daily drop deviation of 7%, and a daily fluctuation of 15% [2]. - The net buying from leading brokerage firms amounted to 16.3546 million yuan [2]. Financial Results - According to the semi-annual report released on August 21, the company achieved total operating revenue of 366 million yuan in the first half of the year, a year-on-year decrease of 21.30%. The net profit was -53 million yuan, reflecting a year-on-year decline of 307.10% [2].
济民健康跌8.77%,上榜营业部合计净卖出7636.04万元
Zheng Quan Shi Bao· 2025-09-05 11:29
Group 1 - Jimin Health (603222) experienced a decline of 8.77% on the trading day, with a turnover rate of 17.07% and a transaction amount of 949.7 million yuan, showing a fluctuation of 7.12% [1] - The stock was listed on the Shanghai Stock Exchange's watch list due to a daily price deviation of -10.01%, with a total net sell of 76.36 million yuan from brokerage seats [1] - Over the past six months, the stock has appeared on the watch list 11 times, with an average price increase of 1.50% the day after being listed and an average increase of 5.91% over the following five days [1] Group 2 - As of September 4, the latest margin trading balance for the stock was 16.9 million yuan, with a financing balance of 16.9 million yuan and a securities lending balance of 91,000 yuan [2] - In the past five days, the financing balance decreased by 73.94 million yuan, representing a decline of 30.40%, while the securities lending balance increased by 7,890 yuan, showing a growth of 649.41% [2] - The company reported a revenue of 366 million yuan for the first half of the year, a year-on-year decrease of 21.30%, and a net profit of -52.7 million yuan [2] Group 3 - On September 5, the top five buying brokerage seats included Guosen Securities (Shenzhen) with a purchase amount of 10.28 million yuan, while the top selling brokerage was Guotai Junan Securities with a selling amount of 41.93 million yuan [3] - The second and third largest buying brokerage seats were Dongguan Securities (Nanjing) and Guosen Securities (Zhejiang), with purchase amounts of 9.59 million yuan and 9.50 million yuan respectively [3] - The second and third largest selling brokerage seats were Zhongtai Securities (Hubei) and Zhongtai Securities (Changzhou), with selling amounts of 25.79 million yuan and 19.53 million yuan respectively [3]
济民健康跌8.77%,上榜营业部合计净卖出7636.04万元
Zheng Quan Shi Bao Wang· 2025-09-05 09:59
Core Viewpoint - Jimin Health (603222) experienced a significant decline of 8.77% in its stock price, with a trading volume of 9.47 billion yuan and a turnover rate of 17.07% on the day of the report [1][2]. Trading Activity - The stock was listed on the Shanghai Stock Exchange's watch list due to a daily price deviation of -10.01%, with a total net sell of 76.36 million yuan from brokerage seats [2]. - The top five brokerage seats accounted for a total transaction volume of 171 million yuan, with buying amounting to 47.21 million yuan and selling at 124 million yuan, resulting in a net sell of 76.36 million yuan [2]. - The largest buying brokerage was Guosen Securities, Shenzhen, with a purchase amount of 10.28 million yuan, while the largest selling brokerage was Guotai Junan Securities, with a sell amount of 41.93 million yuan [2]. Stock Performance and Fund Flow - Over the past six months, the stock has appeared on the watch list 11 times, with an average price increase of 1.50% the day after being listed and an average increase of 5.91% in the following five days [3]. - On the day of the report, the stock saw a net outflow of 9.61 million yuan in principal funds, with a significant outflow of 10.44 million yuan from large orders, while smaller orders saw a net inflow of 835,000 yuan [3]. - In the past five days, the total net outflow of principal funds reached 69.01 million yuan [3]. Financial Performance - According to the semi-annual report released on August 21, the company achieved a revenue of 366 million yuan in the first half of the year, representing a year-on-year decline of 21.30%, and reported a net loss of 52.70 million yuan [4].
济民健康控股股东拟减持1575万股 此前套现3.69亿元
Zhong Guo Jing Ji Wang· 2025-09-05 07:53
Summary of Key Points Core Viewpoint - Jimin Health (603222.SH) announced a share reduction plan by its major shareholder, Shuangge Group, which holds 127,983,520 shares, accounting for 24.37% of the company's total shares. The reduction is due to Shuangge Group's funding needs and will involve selling up to 15,752,718 shares, or 3% of the total shares, over a three-month period starting 15 trading days after the announcement [1][2]. Group 1: Share Reduction Details - Shuangge Group plans to reduce its holdings through two methods: a maximum of 5,250,906 shares via centralized bidding and 10,501,812 shares through block trading [2]. - The reduction period is set from September 29, 2025, to December 26, 2025 [2]. - Based on the closing price of 11.52 yuan on September 4, the total cash to be raised from the reduction is approximately 181 million yuan [1]. Group 2: Shareholder Background - Shuangge Group is the controlling shareholder of Jimin Health, with actual control held by the Li Xianyu family, which owns 77,277,020 shares, representing 14.72% of the total shares [2]. - The shares held by Shuangge Group were acquired prior to the company's IPO and through capital reserve conversion [2]. Group 3: Historical Share Reductions - Since the first reduction on July 9, 2020, Shuangge Group has cumulatively reduced its holdings by 20,250,000 shares, realizing approximately 36.9 million yuan in cash [3]. - The historical data shows various reduction transactions with different average prices and amounts, totaling 20,250,000 shares and 368.58 million yuan in cash [4].
A股异动丨济民健康跌近9%,实控人之一致行动人拟减持不超3%股份
Ge Long Hui A P P· 2025-09-05 06:01
Core Viewpoint - Jimin Health (603222.SH) experienced a decline of 8.85%, closing at 10.5 yuan, with a total market capitalization of 5.513 billion yuan [1] Group 1: Company Actions - The controlling shareholder and concerted action party, Shuangge Group Co., Ltd., plans to reduce its holdings in the company by a total of no more than 15.7527 million shares, which is up to 3% of the company's total share capital, within three months after 15 trading days [1]
证券代码:603222 证券简称:济民健康 公告编号:2025-044
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-09-05 04:54
Core Viewpoint - The major shareholder, Shuangge Group, plans to reduce its stake in Jimin Health Management Co., Ltd. due to funding needs, which may impact the company's stock performance and investor sentiment [2][3]. Shareholder Holdings - As of the announcement date, Shuangge Group holds 127,983,520 shares in Jimin Health, representing 24.37% of the total share capital [2]. Reduction Plan Details - Shuangge Group intends to reduce its holdings by up to 15,752,718 shares, not exceeding 3% of the total share capital, through centralized bidding and block trading methods [3]. - The reduction will occur within three months after the announcement, starting fifteen trading days later, with a limit of 1% through centralized bidding and 2% through block trading [3]. Shareholder Commitments - The major shareholder and related parties have made commitments regarding share transfer restrictions, including a lock-up period of 36 months from the listing date [5]. - If the stock price falls below the issue price for 20 consecutive trading days within six months post-listing, the lock-up period will automatically extend by six months [6]. Compliance and Regulations - The reduction plan complies with relevant laws and regulations, including the Securities Law of the People's Republic of China and the Shanghai Stock Exchange rules [7].
国办印发释放体育消费潜力“20条”;央行开展1万亿元买断式逆回购操作|南财早新闻
2 1 Shi Ji Jing Ji Bao Dao· 2025-09-04 23:52
1、9月4日,国务院办公厅对外印发《关于释放体育消费潜力进一步推进体育产业高质量发展的意见》 (下文简称《意见》),提出6方面20条重点举措。《意见》明确提出到2030年,培育一批具有世界影 响力的体育企业和体育赛事,体育产业发展水平大幅跃升,总规模超过7万亿元。详情>>> 2、针对商务部近日公布中国首起反规避调查裁决,商务部新闻发言人4日回应:反规避调查符合中国法 律和世贸规则,中国一贯审慎、克制实施贸易救济措施,坚定维护公平和自由贸易。 (原标题:国办印发释放体育消费潜力"20条";央行开展1万亿元买断式逆回购操作|南财早新闻) 今日关注 3、央行9月4日公告称,9月5日,将以固定数量、利率招标、多重价位中标方式开展10000亿元买断式逆 回购操作,期限为3个月(91天),以保持银行体系流动性充裕。由于本月还有3000亿元6个月期买断式 逆回购到期,业内专家预计,本月央行还会开展一次6个月期买断式逆回购操作,以应对流动性收紧态 势。不排除后续超额续作6个月期买断式逆回购的可能性。 宏观经济 1、9月4日,工业和信息化部、市场监督管理总局印发《电子信息制造业2025—2026年稳增长行动方 案》。主要预期目 ...
公告精选︱罗曼股份:拟以1.96亿元收购武桐高新的39.2308%的股权;中环海陆:终止筹划公司控制权变更事项 股票复牌





Ge Long Hui· 2025-09-04 23:42
Key Points - Zhonghuan Hailu terminated the planning of the change of company control and resumed trading [1][2] - Shida Shenghua plans to establish a subsidiary with an investment of 25 million yuan to build a 53,000 tons/year calcium chloride project [1] - Southeast Network Frame won a bid for approximately 1.686 billion yuan for the Pujiang Street Five Villages joint planning and development project [1] - Roman Co. intends to acquire 39.2308% equity of Wutong Gaoxin for 196 million yuan [1] - Torch Electronics completed a share repurchase, having repurchased shares worth 49.9907 million yuan [1] - Jiangling Motors reported cumulative sales of 226,500 vehicles from January to August, a year-on-year increase of 5.67% [1] - Wen's Co. reported August sales revenue of 2.956 billion yuan for broilers and 4.825 billion yuan for live pigs [2] - Some directors and senior management of Shanghai Caishi plan to increase their holdings by no less than 6 million yuan [1] - Actual controller of Gongdong Medical, Shi Huiyong, plans to reduce holdings by no more than 4.4099 million shares through block trading [1] - Shida Shenghua's subsidiary establishment and investment in the calcium chloride project indicates growth in the chemical industry [1]
16天9板!603222,控股股东拟减持
证券时报· 2025-09-04 15:17
Core Viewpoint - Jimin Health (603222) has experienced significant stock price increases, with a maximum cumulative rise of over 70% from August 14 to September 4, 2025, including 9 trading days of limit-up [1][2]. Group 1: Stock Performance - Jimin Health's stock price closed at 11.52 CNY per share on September 4, 2025, after reaching a high of 12.67 CNY and a low of 7.24 CNY during the period [1][2]. - The stock recorded a total trading volume of 13.69 million shares, with a turnover amounting to 14.145 billion CNY and a turnover rate of 260.81% [2]. Group 2: Shareholder Actions - The controlling shareholder, Shuangge Group, plans to reduce its holdings by up to 15,752,718 shares, representing no more than 3% of the total share capital, due to its own funding needs [4]. - The reduction will occur through a combination of centralized bidding (up to 5,250,906 shares) and block trading (up to 10,501,812 shares) between September 29 and December 26, 2025 [4]. Group 3: Financial Performance - For the first half of 2025, Jimin Health reported total revenue of 366 million CNY, a year-on-year decline of 21.30% [5]. - The company incurred a net loss attributable to shareholders of 52.6959 million CNY, primarily due to reduced income from medical device sales and inventory write-downs [5]. - The net cash flow from operating activities was negative, attributed to decreased cash receipts from sales and increased cash outflows due to litigation-related fund freezes [5].
40股每笔成交量增长超50%
Zheng Quan Shi Bao Wang· 2025-09-04 14:54
Market Overview - As of September 4, the Shanghai Composite Index closed at 3765.88 points, with a decline of 1.25%. The Shenzhen Component Index closed at 12118.70 points, down 2.83%, and the ChiNext Index closed at 2776.25 points, decreasing by 4.25% [1] Trading Activity - A total of 2131 stocks saw an increase in average transaction volume, with 40 stocks experiencing a rise of over 50% in average transaction volume. Conversely, 2426 stocks reported a decrease in average transaction volume [1] - Notable stocks with significant increases in average transaction volume include Aishida (爱仕达) with a 207.02% increase, Huijia Times (汇嘉时代) with 184.35%, and Victory Precision (胜利精密) with 158.81% [1] Active Stocks - The stocks with the highest increase in transaction volume and transaction count include: - Spring兴精工 with a transaction count increase of 2190.85% - Hanzhong Precision (汉钟精机) with a transaction count increase of 827.07% - Lushan New Materials (鹿山新材) with a transaction count increase of 476.62% [1] Notable Performers - The following stocks showed significant daily gains: - Aishida (爱仕达) increased by 10.03% - Huijia Times (汇嘉时代) rose by 10.05% - Victory Precision (胜利精密) gained 10.09% [1] - Other notable performers include: - Strait Environmental (海峡环保) with a 10.08% increase - An彩高科 with a 9.92% increase [1] Additional Trading Insights - The average transaction volume and transaction count for several stocks also showed substantial increases, indicating heightened trading activity. For example, Tianchuang Fashion (天创时尚) had a transaction count increase of 204.19% [1][2]